Literature DB >> 2463270

Measurement of protein HC (alpha 1 microglobulin) and protein HC-IgA complex in different body fluids.

J L Fernández-Luna1, F Leyva-Cobián, E Méndez.   

Abstract

Protein HC and protein HC-IgA complex were measured in 18 different types of fluid sample from healthy subjects and patients with different illnesses to determine if the concentrations of protein HC and protein HC-IgA complexes could be used to monitor certain diseases, when measured separately. The normal values for HC ranged from between 0.30 mg/l in saliva and 11.7 mg/l in blood plasma. HC-IgA complex has a greater range, from undetectable concentrations (urine, colostrum, and cervical mucus) up to 59.2 mg/l in blood plasma. Undetectable concentrations of HC-IgA complex were also shown in serum from patients with IgA immune deficiency and in cerebrospinal fluid from patients with multiple sclerosis. Increased concentrations of HC were noted in bronchoalveolar fluid from a patient with pulmonary alveolar proteinosis, serum from patients with Behcet's syndrome, and in synovial fluid from patients with gout, chondrocalcinosis, and rheumatoid arthritis. On the other hand, the concentrations of HC-IgA complex were raised only in those patients with pulmonary alveolar proteinosis or rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2463270      PMCID: PMC1141726          DOI: 10.1136/jcp.41.11.1176

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  17 in total

1.  alpha1-Microglobulin, a new low molecular weight plasma protein.

Authors:  L Svensson; U Ravnskov
Journal:  Clin Chim Acta       Date:  1976-12       Impact factor: 3.786

2.  Characterization of alpha 1-microglobulin in human colostrum and milk.

Authors:  I Bernier; A Dautigny; P Jollès
Journal:  Experientia       Date:  1980-12-15

3.  Diurnal variation of serum alpha-1-microglobulin in normal subjects.

Authors:  Y Itoh
Journal:  Nephron       Date:  1981       Impact factor: 2.847

Review 4.  Update on the clinical diagnosis, management, and pathogenesis of pulmonary alveolar proteinosis (phospholipidosis).

Authors:  W D Claypool; R M Rogers; G M Matuschak
Journal:  Chest       Date:  1984-04       Impact factor: 9.410

5.  A chemotactic inhibitor in synovial fluid.

Authors:  Y Matzner; R E Partridge; B M Babior
Journal:  Immunology       Date:  1983-05       Impact factor: 7.397

6.  Human alpha1-microglobulin. Purification procedure, chemical and physiochemical properties.

Authors:  B Ekström; I Berggård
Journal:  J Biol Chem       Date:  1977-11-25       Impact factor: 5.157

7.  A comparative study of serum alpha 1-microglobulin and beta 2-microglobulin levels in cancerous and other diseases.

Authors:  K Takagi; Y Itoh; H Enomoto; Y Koyamaishi; K Maeda; T Kawai
Journal:  Clin Chim Acta       Date:  1980-12-08       Impact factor: 3.786

8.  Isolation of human complex-forming glycoprotein, heterogeneous in charge (protein HC), and its IgA complex from plasma. Physiochemical and immunochemical properties, normal plasma concentration.

Authors:  A O Grubb; C López; L Tejler; E Mendez
Journal:  J Biol Chem       Date:  1983-12-10       Impact factor: 5.157

9.  Human alpha 1-microglobulin levels in neurological disorders.

Authors:  Y Itoh; H Enomoto; K Takagi; T Obayashi; T Kawai
Journal:  Eur Neurol       Date:  1983       Impact factor: 1.710

10.  Conformational studies of the human complex-forming glycoprotein, heterogeneous in charge: protein HC.

Authors:  J G Gavilanes; C López-Otín; F Gavilanes; E Méndez
Journal:  Biochemistry       Date:  1984-03-13       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.